Table 1.

Estimates (January 1, 2013) and projections (January 1, 2017) of breast cancer mortality, and incidence and prevalence of MBC including de novo and recurrence disease in the United States

Number of women at January 1, 2013
Breast cancer deathsMBC incidenceMBC prevalence
Age, yU.S. female populationObservedEstimatedDe novo (Observed)De novo and recurrence (Estimated)De novo (Observed)De novo and recurrence (Estimated)
15–3952,450,8449969767051,8701,6044,205
40–4921,199,1163,5303,4161,4225,1294,73615,684
50–5922,400,3087,9798,0952,9949,9628,95030,642
60–6917,143,15510,0719,8883,20011,48111,00236,194
70–7010,011,1318,6508,6172,6789,3427,74027,232
80–997,338,87111,21611,1761,96712,5604,86524,665
15–99130,543,42542,44242,16912,96650,34438,897138,622
Number of women at January 1, 2017 (Projections*)
Breast cancer deathsMBC incidenceMBC prevalence
Age, yU.S. female populationObservedEstimatedDe novo (Observed)De novo and recurrence (Estimated)De novo (Observed)De novo and recurrence (Estimated)
15–3954,104,4761,0562,0504,711
40–4920,471,6553,3175,05216,019
50–5922,240,8988,10310,04232,573
60–6919,420,21111,15113,03742,450
70–7011,771,88010,03510,91032,731
80–997,602,52611,76713,30226,310
15–99135,611,64645,42954,394154,794
  • *NOTE: Projections are based on dynamic projections of population growth and aging from the U.S. Census Bureau and constant projections of breast cancer mortality and of MBC survival.